| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $650.00 | 16 | |
A-83-01 is a selective inhibitor of TGF-beta type I receptor (ALK5). While it primarily targets ALK5, it may indirectly affect EML5 through its role in TGF-beta signaling pathways. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $90.00 $240.00 | 17 | |
Ro 31-8220 is a kinase inhibitor targeting various protein kinases, including protein kinase C (PKC). PKC can regulate microtubule dynamics, and EML5's function in microtubule organization may be influenced by Ro 31-8220's impact on PKC. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
MLN8237, also known as Alisertib, is an Aurora A kinase inhibitor. EML5 is linked to the regulation of centrosome function and microtubule organization, and Aurora A kinase plays a role in these processes, so inhibiting it with MLN8237 may indirectly affect EML5. | ||||||
MLN 8054 | 869363-13-3 | sc-484828 | 5 mg | $398.00 | ||
MLN8054 is an inhibitor of Aurora A kinase, similar to Alisertib (MLN8237). By targeting Aurora A kinase, it may indirectly affect EML5's role in centrosome regulation and microtubule organization. | ||||||
CGP-60474 | 164658-13-3 | sc-507525 | 5 mg | $165.00 | ||
CGP60474 is an inhibitor of multiple kinases, including CDKs, which are known to play a role in microtubule dynamics. Inhibition of CDKs with CGP60474 may indirectly affect EML5 functions related to the microtubules. | ||||||